Today: 9 June 2026
Vodafone share price hits fresh 52-week high as buyback rolls on ahead of Feb 5 update
2 February 2026
1 min read

Vodafone share price hits fresh 52-week high as buyback rolls on ahead of Feb 5 update

London, Feb 2, 2026, 08:48 GMT — Regular session

  • Vodafone shares climbed roughly 1% in early Monday trading, hitting a fresh 52-week peak
  • Company announced additional share repurchases as part of its ongoing buyback programme
  • Investors are turning their attention to the Feb 5 quarterly trading update and the planned interim dividend payment.

Vodafone Group shares hit a new 52-week peak on Monday, climbing nearly 1% in early London trade. The FTSE 100 telecoms giant was up 1.05 pence to 108.45 pence, starting the day at 107.95 pence, according to LSE figures.

Vodafone continues its streak of returning cash to shareholders ahead of a packed week. The telecom giant will release its third-quarter FY26 trading update on Feb 5, coinciding with an interim dividend payment.

Vodafone disclosed in a regulatory filing that it acquired 1,523,376 ordinary shares on Jan 30, paying a volume-weighted average price of 106.94 pence. The top price reached 107.35 pence. The company said it plans to hold these shares in treasury.

Treasury stock sits with the company, cutting the number of shares out there for trading. While buybacks don’t alter the core business, they can boost earnings per share as time goes on.

In the short term, focus shifts fast from capital returns to operational figures. A trading update usually delivers a quick look at service revenue — the main fees customers pay for connectivity — along with remarks on cost control and cash flow.

Vodafone has leaned heavily on a turnaround narrative in recent quarters, and the stock’s push to a one-year high raises the bar a little. Investors will want evidence the momentum is holding, not just that the company is shrinking the share count.

Yet the rally lacks solid new operating data to back it up. Should Thursday’s update reveal softer trading in key markets or increased spending requirements, the stock could quickly lose its gains.

Vodafone’s Q3 FY26 trading update arrives on Feb 5. Traders will be focused on any changes in the tone around revenue trends and cash generation.

Stock Market Today

  • SpaceX IPO Raises Twice Planned Amount as Order Books Oversubscribe Ahead of Nasdaq Debut
    June 9, 2026, 9:00 AM EDT. SpaceX's initial public offering (IPO) has been significantly oversubscribed, with demand reaching approximately $150 billion, double the $75 billion the company aims to raise. Several institutional investors placed orders exceeding $10 billion each, signaling strong market interest ahead of SpaceX's planned Nasdaq debut. The high demand underscores investor confidence in the aerospace firm's growth prospects amid its expansion in satellite and space exploration sectors.

Latest articles

AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Grab Stock Barely Moves As Taiwan Push And Singapore Merchant Plan Put Growth Back In Focus

Grab Stock Barely Moves As Taiwan Push And Singapore Merchant Plan Put Growth Back In Focus

9 June 2026
Grab shares hovered near $3.33 in pre-market trading after unveiling a new Singapore merchant programme and Taiwan partner commitments, as investors weigh growth initiatives against regulatory hurdles and consumer spending pressure; the stock’s muted move reflects ongoing uncertainty around its proposed foodpanda Taiwan acquisition and potential margin impacts from promotions.
ST Engineering share price slips after NeuSAR-2 satellite plan and Singapore’s new space agency
Previous Story

ST Engineering share price slips after NeuSAR-2 satellite plan and Singapore’s new space agency

Samsung Electronics stock price dives 6% in Seoul selloff — what to watch before Tuesday’s open
Next Story

Samsung Electronics stock price dives 6% in Seoul selloff — what to watch before Tuesday’s open

Go toTop